Richard Close
Stock Analyst at Canaccord Genuity
(4.55)
# 952
Out of 4,339 analysts
615
Total ratings
49.8%
Success rate
9.6%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Upgraded: Buy | $19 → $30 | $25.05 | +19.76% | 19 | May 19, 2026 | |
| DOCS Doximity | Maintained: Buy | $34 → $30 | $19.52 | +53.69% | 27 | May 14, 2026 | |
| EVH Evolent Health | Maintained: Buy | $4 → $6 | $3.83 | +56.66% | 78 | May 12, 2026 | |
| HCAT Health Catalyst | Maintained: Buy | $2 | $1.26 | +58.73% | 31 | May 12, 2026 | |
| TALK Talkspace | Maintained: Hold | $5.25 | $5.20 | +0.96% | 10 | May 12, 2026 | |
| DCGO DocGo | Maintained: Hold | $1 | $0.63 | +58.73% | 20 | May 12, 2026 | |
| PRVA Privia Health Group | Rated: Buy | $35 → $34 | $22.20 | +53.15% | 24 | May 8, 2026 | |
| LFST LifeStance Health Group | Reiterated: Buy | $10 → $11 | $7.57 | +45.31% | 8 | May 8, 2026 | |
| OMDA Omada Health | Maintained: Buy | $22 → $24 | $16.10 | +49.07% | 9 | May 8, 2026 | |
| HSTM HealthStream | Rated: Hold | $21 → $24 | $24.37 | -1.52% | 62 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $16 | $10.36 | +54.44% | 27 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.2 | $3.61 | -11.36% | 27 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $63 | $52.98 | +18.91% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $6.59 | +51.75% | 75 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $19.72 | +52.13% | 10 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 → $22 | $8.95 | +145.81% | 22 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $13 | $0.0001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $110 | $154.12 | n/a | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.5 → $2 | $0.0001 | n/a | 28 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $89 → $83 | $60.91 | n/a | 45 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $21 | $4.75 | n/a | 60 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $24 | $21.34 | n/a | 12 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 | $21.67 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $179.08 | n/a | 1 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $55 | $25.95 | n/a | 1 | Sep 11, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $200.37 | n/a | 1 | Nov 18, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $20 | $7.15 | n/a | 1 | Nov 23, 2009 |
Progyny
May 19, 2026
Upgraded: Buy
Price Target: $19 → $30
Current: $25.05
Upside: +19.76%
Doximity
May 14, 2026
Maintained: Buy
Price Target: $34 → $30
Current: $19.52
Upside: +53.69%
Evolent Health
May 12, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $3.83
Upside: +56.66%
Health Catalyst
May 12, 2026
Maintained: Buy
Price Target: $2
Current: $1.26
Upside: +58.73%
Talkspace
May 12, 2026
Maintained: Hold
Price Target: $5.25
Current: $5.20
Upside: +0.96%
DocGo
May 12, 2026
Maintained: Hold
Price Target: $1
Current: $0.63
Upside: +58.73%
Privia Health Group
May 8, 2026
Rated: Buy
Price Target: $35 → $34
Current: $22.20
Upside: +53.15%
LifeStance Health Group
May 8, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $7.57
Upside: +45.31%
Omada Health
May 8, 2026
Maintained: Buy
Price Target: $22 → $24
Current: $16.10
Upside: +49.07%
HealthStream
May 6, 2026
Rated: Hold
Price Target: $21 → $24
Current: $24.37
Upside: -1.52%
May 6, 2026
Maintained: Buy
Price Target: $14 → $16
Current: $10.36
Upside: +54.44%
May 6, 2026
Maintained: Buy
Price Target: $3.2
Current: $3.61
Upside: -11.36%
May 6, 2026
Maintained: Buy
Price Target: $53 → $63
Current: $52.98
Upside: +18.91%
Apr 30, 2026
Maintained: Buy
Price Target: $10
Current: $6.59
Upside: +51.75%
Apr 30, 2026
Maintained: Buy
Price Target: $30
Current: $19.72
Upside: +52.13%
Mar 31, 2026
Rated: Buy
Price Target: $33 → $22
Current: $8.95
Upside: +145.81%
Mar 10, 2023
Maintained: Buy
Price Target: $50 → $13
Current: $0.0001
Upside: n/a
Feb 27, 2023
Maintained: Hold
Price Target: $110
Current: $154.12
Upside: n/a
May 12, 2022
Maintained: Hold
Price Target: $2.5 → $2
Current: $0.0001
Upside: n/a
Nov 19, 2021
Maintained: Hold
Price Target: $89 → $83
Current: $60.91
Upside: n/a
Nov 8, 2021
Maintained: Buy
Price Target: $18 → $21
Current: $4.75
Upside: n/a
Aug 4, 2021
Maintained: Buy
Price Target: $22 → $24
Current: $21.34
Upside: n/a
Feb 22, 2019
Maintained: Hold
Price Target: $33
Current: $21.67
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $135
Current: $179.08
Upside: n/a
Sep 11, 2013
Downgraded: Hold
Price Target: $55
Current: $25.95
Upside: n/a
Nov 18, 2010
Maintained: Hold
Price Target: n/a
Current: $200.37
Upside: n/a
Nov 23, 2009
Upgraded: Hold
Price Target: $20
Current: $7.15
Upside: n/a